Cargando…
Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice
BACKGROUND: Type-2 Diabetes is a major health concern in the United States and other Westernized countries, with prevalence increasing yearly. There is a need to better model and predict adverse drug reactions, drug-induced liver injury, and drug efficacy in this population. Because transporters sig...
Autores principales: | More, Vijay R, Wen, Xia, Thomas, Paul E, Aleksunes, Lauren M, Slitt, Angela L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416584/ https://www.ncbi.nlm.nih.gov/pubmed/22524730 http://dx.doi.org/10.1186/1476-5926-11-1 |
Ejemplares similares
-
Enhanced Nrf2 Activity Worsens Insulin Resistance, Impairs Lipid Accumulation in Adipose Tissue, and Increases Hepatic Steatosis in Leptin-Deficient Mice
por: Xu, Jialin, et al.
Publicado: (2012) -
Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease
por: Shimpi, Prajakta C., et al.
Publicado: (2017) -
Establishment of Metabolism and Transport Pathways in the Rodent and Human Fetal Liver
por: Moscovitz, Jamie E., et al.
Publicado: (2013) -
In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs
por: George, Blessy, et al.
Publicado: (2021) -
Leptin Therapy Reverses Hyperglycemia in Mice With Streptozotocin-Induced Diabetes, Independent of Hepatic Leptin Signaling
por: Denroche, Heather C., et al.
Publicado: (2011)